mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.091 |
0.01 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.01 |